Johnson & Johnson (NYSE:JNJ) said today it inked a deal between its J&J Services biz and a subsidiary of HP to collaborate on using 3D printing tech to create “better health care outcomes at reduced costs.”

Through the collaborative deal, the companies said they will combine scientific, clinical, material science and technological expertise to develop products that can be manufactured and customized to the individual patient or consumer.

“The intersection of technology and health care is spurring innovation that will have a profound impact on patients and consumers all over the world. Combined with advances in data mining and software, 3D printing could enable distributed manufacturing models and patient-specific products, therapies and solutions that deliver better outcomes, better economics and improved global accessibility.  This collaboration with HP Inc. exemplifies our commitment to harnessing new technology to improve outcomes and reduce costs across the health continuum,” J&J group worldwide chair Sandra Peterson said in prepared remarks.

Initially, the partnership will focus on personalizing instruments and software for patient-specific healthcare devices. The companies said they anticipate that 3D printing technology will lead to innovation in orthopaedics, eye health and health-related consumer products.

“Advances in 3D printing technology have the potential to break historical paradigms of health care delivery in ways that are not feasible in traditional manufacturing processes. Together with Johnson & Johnson we have the potential to create opportunities and innovations in health care to improve patients’ lives that neither company could develop alone,” HP 3D printing biz prez Stephen Nigro said in a press release.